#

Drugs

: 8
Photo: Andrei Doronichevs personal archive.
Review·
Five biotech companies that Andrei Doronichev is keeping an eye on
Photo: Evgenia Eliseeva / Andrei Doronichevs personal archive
Review·
'New leaders will rise from the ashes': An interview with Andrey Doronichev
The main risk associated with the failure of the trials is a “potential loss of confidence” in the company, according to Jefferies: based on their information, AstraZeneca’s management was confident in the effectiveness of the drug’s development / Photo: Declan Sun / unsplash
News·
AstraZeneca lost $27 billion in market capitalization in a single day: its drug failed clinical trials
Galderma shares plummeted 6% on the Zurich Stock Exchange / Photo: Body Stock / Shutterstock
News·
Shares of pharmaceutical company Galderma plummeted: The U.S. has halted sales of a Botox generic
Generate Bio has listed on the Nasdaq with the ticker GENB / Photo: Photoroyalty/Shutterstock
News·
IPO Generate Biomedicines: shares of AI drug development platform become available
Pfizer will buy a company that develops obesity remedies. Its shares soared 60%
News·
Pfizer will buy a company that develops obesity remedies. Its shares soared 60%
Shares in biotech Sarepta soar after FDA allows shipments of Elevidys to resume
Small Caps·
Shares in biotech Sarepta soar after FDA allows shipments of Elevidys to resume
Eli Lilly is entering a market valued at $30 billion, can it beat the competition?
News·
Eli Lilly is entering a market valued at $30 billion, can it beat the competition?